Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-24-008945

Executive Vice President gave up 56,316 shares (to pay taxes)

  • Executive Vice President acquired 111,060 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shah Nikita Executive Vice President 2024-03-01 Option exercise +28,957 365,879 D
Shah Nikita Executive Vice President 2024-03-01 Shares withheld for taxes −15,181 $5.47 $83,040 350,698 D
Shah Nikita Executive Vice President 2024-03-03 Option exercise +36,232 386,930 D
Shah Nikita Executive Vice President 2024-03-03 Shares withheld for taxes −18,153 $5.47 $99,297 368,777 D
Shah Nikita Executive Vice President 2024-03-03 Option exercise +45,871 414,648 D
Shah Nikita Executive Vice President 2024-03-03 Shares withheld for taxes −22,982 $5.47 $125,712 391,666 D
Derivatives
Shah Nikita Executive Vice President 2024-03-01 Option exercise · Restricted Stock Units −28,957 28,958 D
Shah Nikita Executive Vice President 2024-03-03 Option exercise · Restricted Stock Units −36,232 72,464 D
Shah Nikita Executive Vice President 2024-03-03 Option exercise · Restricted Stock Units −45,871 137,615 D
Shah Nikita Executive Vice President 2024-03-04 Grant or award · Restricted Stock Units +143,519 143,519 D
Shah Nikita Executive Vice President 2024-03-04 Grant or award · Performance-Based Restricted Stock Units +287,038 287,038 D
Loading xslF345X05/wk-form4_1709674499.xml…